Literature DB >> 26629060

Prognosis of patients with coronary artery disease treated in different therapy units at department of cardiology: a retrospective cohort study.

Cong Fu1, Yuyu Yao1, Xin Wang1, Chaojun Yu2, Genshan Ma1.   

Abstract

BACKGROUND: Coronary artery disease (CAD) is a major health problem in global. Benefit from different care unit for various type of CAD is remaining unknown. We investigate if coronary care unit (CCU) reduces the incidence of major adverse cardiovascular events (MACEs).
METHOD: 806 CAD patients including stable angina (SA) and acute coronary syndrome (ACS) who treated in department of cardiology were involved in the study as two groups. Each group involved two subgroups according to the therapy unit including CCU and normal unit. 12-48 months follow-up was carried out. The primary end point was all cause mortality.
RESULTS: For SA, death from any cause occurred in 1.0% of the patients in the normal group (1 of 108), as compared with 5.1% in the CCU group (3 of 59) (hazard ratio [HR], 0.164; 95% confidence interval [CI], 0.017 to 1.580; P=0.118). Kaplan-Meier survival analysis showed that there were no significant differences between the two subgroups with respect to the risk of death (P=0.074), revascularization (P=0.660), stroke (P=0.497), heart failure (P=0.658) and hemorrhage (P=0.096). For ACS, death occurred in 1.9% of the patients in the normal subgroup (5 of 267), as compared with 1.3% in the CCU subgroup (5 of 372) (HR, 1.403; 95% CI, 0.406-4.846; P=0.593). Kaplan-Meier survival analysis showed that there were no significant differences between the two subgroups with respect to the risk of death (P=0.591), revascularization (P=0.996), stroke (P=0.425), heart failure (P=0.625).
CONCLUSION: CAD patients treated in CCU obtain little benefits compared with normal.

Entities:  

Keywords:  Coronary artery disease; coronary care unit; outcomes

Year:  2015        PMID: 26629060      PMCID: PMC4658949     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Authors:  Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

2.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

3.  Beta-blockers in asymptomatic coronary artery disease: no benefit or no evidence?

Authors:  Philippe Gabriel Steg; Ranil De Silva
Journal:  J Am Coll Cardiol       Date:  2014-07-22       Impact factor: 24.094

4.  Outcome comparison of 600 mg versus 300 mg loading dose of clopidogrel for patients with ST-elevation myocardial infarction: a meta-analysis.

Authors:  Ankur Vyas; Ramzi El Accaoui; Amy Blevins; Wassef Karrowni
Journal:  Postgrad Med       Date:  2014-09       Impact factor: 3.840

5.  Anti-oxidative stress effect of loading-dose rosuvastatin prior to percutaneous coronary intervention in patients with acute coronary syndrome: a prospective randomized controlled clinical trial.

Authors:  Dong Liang; Qian Zhang; Hexu Yang; Ran Zhang; Wei Yan; Haokao Gao; Jinda Wang; Xiaotian Zhang; Yundai Chen; Feng Cao
Journal:  Clin Drug Investig       Date:  2014-11       Impact factor: 2.859

6.  Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons.

Authors:  Amir Qaseem; Stephan D Fihn; Sankey Williams; Paul Dallas; Douglas K Owens; Paul Shekelle
Journal:  Ann Intern Med       Date:  2012-11-20       Impact factor: 25.391

7.  Coronary artery disease in patients clinically diagnosed with myocardial infarction in the medical intensive care unit.

Authors:  Yousang Ko; Chi-Min Park; Wooyoul Kim; Byeong-Ho Jeong; Gee Young Suh; So Yeon Lim; O Jung Kwon; Kyeongman Jeon
Journal:  J Crit Care       Date:  2013-02-18       Impact factor: 3.425

Review 8.  Statins for acute coronary syndrome.

Authors:  Noah Vale; Alain J Nordmann; Gregory G Schwartz; James de Lemos; Furio Colivicchi; Frank den Hartog; Petr Ostadal; Stella M Macin; Anho H Liem; Edward J Mills; Neera Bhatnagar; Heiner C Bucher; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2014-09-01

9.  Unstable angina and non ST elevation acute coronary syndromes.

Authors:  Jorge Ortega-Gil; José M Pérez-Cardona
Journal:  P R Health Sci J       Date:  2008-12       Impact factor: 0.705

10.  Physical activity, smoking, and alcohol consumption in association with incidence of type 2 diabetes among middle-aged and elderly Chinese men.

Authors:  Liang Shi; Xiao-Ou Shu; Honglan Li; Hui Cai; Qiaolan Liu; Wei Zheng; Yong-Bing Xiang; Raquel Villegas
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more
  1 in total

1.  Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin.

Authors:  Hamzah Khan; Reid Gallant; Shubha Jain; Mohammed Al-Omran; Charles De Mestral; Elisa Greco; Mark Wheatcroft; Ashraf Alazonni; Rawand Abdin; Margaret L Rand; Heyu Ni; Mohammad Qadura
Journal:  Medicina (Kaunas)       Date:  2020-10-02       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.